Food, Drug and Cosmetic
Katten offers a Food, Drug and Cosmetic Group along with substantial patent, trademark and copyright capabilities. The Food, Drug and Cosmetic Group is a key component of the firm's Intellectual Property Practice and offers a strong chemical/pharmaceutical and technology base to support the full life cycles of pharmaceuticals, biotechnology drugs, cosmetics, medical devices, diagnostics, foods, dietary supplements and other products regulated by the FDA. The firm has handled a variety of FDA matters involving product clearance and approvals under the Hatch Waxman Amendments, GMPs, enforcement actions, patent and non-patent exclusivity for both large corporations and entrepreneurs. Our attorneys also handle due diligence and contractual language for investment banker and venture capitalist transactions. In addition to Intellectual Property Litigation
, our full range of services includes litigation involving FDA and generic drug approval requirements.